BRUCE A. SILVER, M.D.; WILLIAM R. BELL, M.D.
SILVER BA, BELL WR. Cimetidine Potentiation of the Hypoprothrombinemic Effect of Warfarin. Ann Intern Med. 1979;90:348-349. doi: 10.7326/0003-4819-90-3-348
Download citation file:
Published: Ann Intern Med. 1979;90(3):348-349.
Oral anticoagulants of the coumarin class are subject to both potentiating and inhibitory drug interactions, some of which are clinically significant (1, 2). We report the case of a patient in whom the combined use of warfarin sodium (Coumadin®, Endo Laboratories, Garden City, New Jersey) and cimetidine (Tagamet®, Smith Kline & French Laboratories, Philadelphia, Pennsylvania) led to excessive hypoprothrombinemia, resulting in soft-tissue and urinary tract hemorrhage. Such an adverse effect of the recently marketed cimetidine has not been reported previously.
A 70-year-old white woman presented on 4 October 1978 complaining of pain behind the left knee and gross hematuria. She
Learn more about subscription options.
Register Now for a free account.
Cardiology, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only